Eric Cober
About
Eric Cober is a scholar working on Molecular Medicine, Epidemiology and Pharmacology.
According to data from OpenAlex, Eric Cober has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Medicine, 19 papers in Epidemiology and 15 papers in Pharmacology. Recurrent topics in Eric Cober's work include Antibiotic Resistance in Bacteria (24 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Use and Resistance (12 papers). Eric Cober is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Use and Resistance (12 papers). Eric Cober collaborates with scholars based in United States, Japan and Australia. Eric Cober's co-authors include David van Duin, Sandra S. Richter, Robert A. Bonomo, Keith S. Kaye, Robert A. Salata, Federico Pérez, Vance G. Fowler, Robert C. Kalayjian, Scott Evans and Yohei Doi and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
In The Last Decade
Eric Cober
33 papers receiving 1.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Eric Cober United States | 18 | 1.1k | 633 | 593 | 393 | 243 | 39 | 1.6k | ||
| Alessandro Leonildi Italy | 23 | 1.2k 1.1× | 556 0.9× | 681 1.1× | 474 1.2× | 214 0.9× | 47 | 1.7k | ||
| Angela Raffaella Losito Italy | 15 | 1.4k 1.3× | 792 1.3× | 729 1.2× | 603 1.5× | 397 1.6× | 20 | 2.1k | ||
| Isabel Machuca Spain | 17 | 750 0.7× | 320 0.5× | 342 0.6× | 297 0.8× | 159 0.7× | 43 | 1.2k | ||
| S. Bouchillon United States | 19 | 882 0.8× | 623 1.0× | 371 0.6× | 292 0.7× | 250 1.0× | 34 | 1.4k | ||
| Melanie Baxter Canada | 24 | 841 0.8× | 679 1.1× | 448 0.8× | 291 0.7× | 320 1.3× | 76 | 1.6k | ||
| Timothy Babinchak United States | 17 | 949 0.9× | 540 0.9× | 733 1.2× | 342 0.9× | 421 1.7× | 31 | 1.9k | ||
| M.D. Navarro Spain | 16 | 1.5k 1.4× | 714 1.1× | 396 0.7× | 457 1.2× | 242 1.0× | 21 | 1.8k | ||
| Cristina Pitart Spain | 19 | 633 0.6× | 378 0.6× | 258 0.4× | 188 0.5× | 188 0.8× | 63 | 1.2k | ||
| Sofia Maraki Greece | 20 | 638 0.6× | 611 1.0× | 272 0.5× | 213 0.5× | 167 0.7× | 38 | 1.3k | ||
| Kim Nichol Canada | 19 | 756 0.7× | 674 1.1× | 375 0.6× | 179 0.5× | 207 0.9× | 33 | 1.5k |
Countries citing papers authored by Eric Cober
Since
Specialization
Citations
This map shows the geographic impact of Eric Cober's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Cober with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Cober more than expected).
Fields of papers citing papers by Eric Cober
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eric Cober. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Cober. The network helps show where Eric Cober may publish in the future.
Co-authorship network of co-authors of Eric Cober
This figure shows the co-authorship network connecting the top 25 collaborators of Eric Cober. A scholar is included among the top collaborators of Eric Cober based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Cober. Eric Cober is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Komarow, Lauren, Jesse T. Jacob, Michael J. Satlin, et al.. (2025). 101. Patients with Carbapenem-resistant Klebsiella aerogenes and Enterobacter cloacae complex Colonization or Infection Have Different Baseline Characteristics but Similar Mortality and Clinical Outcomes. Open Forum Infectious Diseases. 12(Supplement_1).
2.
Boutzoukas, Angelique E, Natalie A Mackow, Lauren Komarow, et al.. (2024). Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections. Journal of Antimicrobial Chemotherapy. 79(11). 2916–2922.
3.
Boutzoukas, Angelique E, Eric Cober, Lilian M. Abbo, et al.. (2024). Carbapenem-resistant Enterobacterales in solid organ transplant recipients. American Journal of Transplantation. 25(4). 848–859.
4.
Iovleva, Alina, Christi L. McElheny, Eric Cober, et al.. (2024). In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals. Antimicrobial Agents and Chemotherapy. 68(3). e0125823–e0125823.
5.
Urban, Theresa, Catherine Forbes, Pavithra Srinivas, et al.. (2024). Early de-escalation of antibiotic therapy in hospitalized cellular therapy adult patients with febrile neutropenia. PubMed. 6(1). 59–66.
6.
Miranda, Cyndee, et al.. (2023). Cerebral Abscess Caused by Microascus Cirrosus in a Lung Transplant Recipient. A3875–A3875.
7.
Luterbach, Courtney, Hongqiang Qiu, Rajnikant Sharma, et al.. (2022). A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 66(10). e0059122–e0059122.
8.
Iovleva, Alina, Mustapha M. Mustapha, M. Patrick Griffith, et al.. (2022). Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance. mBio. 13(2). e0275921–e0275921.
9.
Athans, Vasilios, et al.. (2020). Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study. International Journal of Antimicrobial Agents. 55(3). 105886–105886.
10.
Patel, Sagar S., Lisa Rybicki, Dawn Thomas, et al.. (2019). Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation. Hematology/Oncology and Stem Cell Therapy. 13(1). 32–39.
11.
Richter, Sandra S., Eric Cober, Laura J. Rojas, et al.. (2018). Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins. Diagnostic Microbiology and Infectious Disease. 91(1). 89–92.
12.
Cober, Eric, Sandra S. Richter, Federico Pérez, et al.. (2016). Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. Clinical Microbiology and Infection. 22(6). 513–519.
13.
Rojas, Laura J., Madiha Salim, Eric Cober, et al.. (2016). Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality. Clinical Infectious Diseases. 64(6). 711–718.
14.
Duin, David van, Eric Cober, Sandra S. Richter, et al.. (2015). Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae. Infection Control and Hospital Epidemiology. 36(8). 942–948.
15.
Messina, Julia A., Eric Cober, Sandra S. Richter, et al.. (2015). Hospital Readmissions in Patients With Carbapenem-ResistantKlebsiella pneumoniae. Infection Control and Hospital Epidemiology. 37(3). 281–288.
16.
Kovacs, Christopher, Christine Koval, David van Duin, et al.. (2014). Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections. World Journal of Transplantation. 4(2). 43–43.
17.
Duin, David van, Eric Cober, Sandra S. Richter, et al.. (2014). Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clinical Microbiology and Infection. 20(12). O1117–O1120.
18.
Keng, Michael, Paul Elson, Jennifer Sekeres, et al.. (2014). Defining quality and value in a prospective study of an emergency department (ED) febrile neutropenia pathway (FNP).. Journal of Clinical Oncology. 32(15_suppl). 6632–6632.
19.
Wright, Meredith S., Federico Pérez, Lauren Brinkac, et al.. (2014). Population Structure of KPC-Producing Klebsiella pneumoniae Isolates from Midwestern U.S. Hospitals. Antimicrobial Agents and Chemotherapy. 58(8). 4961–4965.
20.
Kaul, Daniel, Susanne Stoelben, Eric Cober, et al.. (2011). First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246. American Journal of Transplantation. 11(5). 1079–1084.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Alessandro Leonildi Breakdown of academic impact, for papers by Angela Raffaella Losito Breakdown of academic impact, for papers by Isabel Machuca Breakdown of academic impact, for papers by S. Bouchillon Breakdown of academic impact, for papers by Melanie Baxter Breakdown of academic impact, for papers by Timothy Babinchak Breakdown of academic impact, for papers by M.D. Navarro Breakdown of academic impact, for papers by Cristina Pitart Breakdown of academic impact, for papers by Sofia Maraki Breakdown of academic impact, for papers by Kim Nichol